The Role of the Electronic Medical Record in Medical Malpractice
Edgar Chou, MD;
Deborah Lorber;
James E. Beasley, Jr, MD, JD;
Heather Hansen, Esq

Original Date: Wednesday, January 14, 2009
 Review Date:
Expiration Date: 1/14/2012
Forum: Department of Medicine Grand Rounds
Length: 49:04
Format: Flash

Objectives • Understand the risk of liability in EMR documentation;
• Recognize risks to patient safety;
• Improve documentation practices to limit the risk of litigation.
Target Audience Internal Medicine, Family Medicine, Physicians Assistants, Registered Nurses and those interested in general medicine topics.
Commercial
Support 		• Drexel University College of Medicine, The Office of the Dean
• Drexel University College of Medicine, Department of Medicine
Speaker
Disclosure 		Edgar Chou MD, James Beasley MD, JD, Heather Hansen Esq, and Deborah Lorber have no commercial relationships to disclose.
The presentation and clinical recommendations reflects the best available evidence from medical literature.
Unlabeled Uses Each faculty person presenting is requested, in writing, to disclose any product that is not labeled for the use under discussion or that the product is still investigational.

Accreditation Statement
Drexel University College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. AMA: The Drexel University College of Medicine designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credit(s) TM. Physicians should only claim credit commensurate with the extent of their participation in the activity. AOA: This program is eligible for 1.5 credit(s) in Category 2A of the American Osteopathic Association.

Faculty Disclosure Statement
It is the policy of Drexel University College of Medicine to insure balance, independence, objectivity, and scientific rigor in all its sponsored educational programs. Speakers at continuing medical education activities are required to disclose to the audience their financial relationships with the manufacturer(s) of any commercial products, goods or services related to the subject matter of the program topic. Any conflicts of interest must be resolved prior to the presentation and announced to the audience. The intent of this disclosure is to allow participants to form their own judgments about the educational content of this activity and determine whether the speaker’s commercial interests influenced the presentation. In addition, speakers are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in their presentation.

view the Virtual Grand Rounds Planning Committee and Commercial Relationships